Stability studies showed an active substance content lower than required, which, according to the Chief Pharmaceutical Inspector, poses a real risk to patients’ health due to the lack of the intended efficacy of the medicinal product. Potential effects: lack of treatment efficacy and possible worsening of the disease.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch 5B0350J, check the batch number of any pack you have and, if it matches, return the medicine to the pharmacy. Patients who have used the medicine from this batch shou...
The Chief Pharmaceutical Inspector withdrew batch 5B0350J of the medicinal product Fingolimod Stada from the market throughout the country and prohibited this batch from being placed on the market, gr...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related